Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy — Stella

Home/Fuchs' Endothelial Dystrophy/

View on ClinicalTrials.gov

Recruiting

Back to Fuchs' Endothelial Dystrophy trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

NorthShore University HealthSystem, Glenview, Illinois

Key details

Phase

Post-approval study

Sponsor

Marian Macsai, MD

Enrollment target

~30 participants

Started

December 2017

Primary completion

December 2021

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 91 Years

Last updated August 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.